Immunoassays for infectious diseases
Imuniniai infekciniai tyrimai yra laboratoriniai tyrimai, kurie skirti nustatyti imuninį atsaką į infekcijas. Šie tyrimai padeda nustatyti, ar organizmas yra ar buvo susidūręs su tam tikra infekcija, ar yra imuninis atsakas į vakcinaciją, arba ar yra susidaręs imunitetas dėl ankstesnės infekcijos.
Services price list
Name of the servicePrice €
| HEPATITIS | |
| HBsAg (Hepatitis B surface antigen) | 14 |
| Anti Hbc Common (Hepatitis B Cores a/b) | 14 |
| Anti Hbc IgM (Hepatitis B Core a/b IgM) | 16 |
| Hbe (Hepatitis B e antigen) | 12 |
| Anti Hbe (hepatitis B e a/b) | 12 |
| AntiHBs quantitative (hepatitis B surface antigen a/b) | 28 |
| Anti HAV IgM (Hepatitis A antibodies) | 20 |
| Anti HCV (Hepatitis C a/b) | 20 |
| Anti Delta Common (Hepatitis D a/b) | 12 |
| HERPES VIRUSES | |
| Anti HSV1 IgG (a-HHV1:herpes lab.,stomatitis, conjuctivitis) | 25 |
| Anti HSV1 IgM (a-HHV1:herpes lab.,stomatitis, conjuctivitis) | 25 |
| Anti HSV2 IgG ((a-HHV2: herpes genitalis/neonatorum) ELISA | 16 |
| Detection of Herpes SV1 and SV2 IgM (common to both types) | 20 |
| Detection of Herpes SV1 and SV2 IgG (common to both types) | 20 |
| Anti Varicella Zoster IgG ((a-HHV3: chickenpox / herpes zoster) | 24 |
| Anti Varicella Zoster IgM ((a-HHV3: chickenpox / herpes zoster) | 16 |
| Anti-EBV IgM (g-HHV4: Infectious Mononucleosis), ELISA | 18 |
| Anti-EBV IgG (g-HHV4: Infectious Mononucleosis), ELISA | 18 |
| Anti CMV IgG (b-HHV5: cytomegalovirus a/b), ELISA | 24 |
| Anti CMV IgM (b-HHV5: cytomegalovirus a/b), ELISA | 29 |
| RUBELLA | |
| Anti Rubella IgG, ELIZA | 20 |
| Anti Rubella IgM | 20 |
| TICK-BORNE ENCEPHALITIS | |
| Anti TBE (FSME) IgG, ELISA | 19 |
| Anti TBE (FSME) IgM, ELISA | 19 |
| LYME DISEASE | |
| Anti Borrelia burgdorferi IgG, ELISA | 19 |
| Anti Borrelia burgdorferi IgM, ELISA | 20 |
| Anti Borrelia burgdorferi IgG (Western blot) | 42 |
| Anti Borrelia burgdorferi IgM (Western blot) | 42 |
| TOXOPLASMOSIS | |
| Anti Toxo IgG, ELISA | 15 |
| Anti Toxo IgM, ELISA | 15 |
| Anti Toxo IgA, ELISA | 16 |
| Anti Toxo IgG Avidity, ELISA | 39 |
| RESPIRATORY INFECTIONS | |
| Anti Chlamydia pneumoniae IgM, ELISA | 16 |
| Anti Chlamydia pneumoniae IgG, ELISA | 16 |
| Anti Mycoplasma pneumoniae IgM, ELISA | 16 |
| Anti Mycoplasma pneumoniae IgG, ELISA | 16 |
| Quanti feron TB Gold test | 65 |
| OTHERS | |
| Anti Morbilli IgG (Measles) | 14 |
| Anti Morbilli IgM (Measles) | 14 |
| Anti Bordetella pertussis IgG (pertussis) | 17 |
| Anti Bordetella pertussis IgA (pertussis) | 25 |
| Anti Helicobacter pylori IgG | 20 |
| Anti Toxocara canis IgG, ELISA | 19 |
| Anti Chlamydia trachomatis IgA, ELISA | 19 |
| Anti Chlamydia trachomatis IgG Elisa | 19 |
| Anti Chlamydia trachomatis IgM Elisa | 19 |
| Anti ŽIV ½ 3 gen su ŽIV 1 O, ELISA | 20 |
| Anti Yersinia enterocolitica IgA | 20 |
| Anti Yersinia enterocolitica IgG | 20 |
| RPR | 8 |
| Antibodies against Trichinella | 19 |
| Antibodies to IgG against Aden virus | 20 |
| TPHA | 12 |
| ŽIV1/2 | 12 |
| Quantification of anti-RBD SARS-CoV-2 (coronavirus) IgG antibodies | 19 |
| IgG klasės antikūnai prieš Parvo virusą | 19 |
| IgM klasės antikūnai prieš Parvo virusą | 23 |